NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.11
Percentage change 7.38	%

Peers: ILMN GH TXG CRSP QGEN TWST CDNA FLGT ONC FATE

| Held by: ARKK ARKG IWM VTI VXF IWN IBB SCHA VTWO PRFZ

Index	RUT	P/E	-	EPS (ttm)	-2.77	Insider Own	11.97%	Shs Outstand	300.04M	Perf Week	24.03%
Market Cap	480.14M	Forward P/E	-	EPS next Y	-0.54	Insider Trans	-1.23%	Shs Float	264.16M	Perf Month	52.38%
Enterprise Value	835.45M	PEG	-	EPS next Q	-0.17	Inst Own	65.85%	Short Float	15.01%	Perf Quarter	25.98%
Income	-656.55M	P/S	3.15	EPS this Y	6.94%	Inst Trans	-12.68%	Short Ratio	4.22	Perf Half Y	-10.61%
Sales	152.36M	P/B	5.24	EPS next Y	48.37%	ROA	-51.89%	Short Interest	39.64M	Perf YTD	-12.57%
Book/sh	0.31	P/C	1.40	EPS next 5Y	27.35%	ROE	-177.29%	52W High	2.72 -41.18%	Perf Year	33.33%
Cash/sh	1.15	P/FCF	-	EPS past 3/5Y	-21.38% -23.55%	ROIC	-83.28%	52W Low	0.85 87.99%	Perf 3Y	-67.08%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	5.67% 11.12%	Gross Margin	-230.61%	Volatility	10.73% 9.56%	Perf 5Y	-52.66%
Dividend TTM	-	EV/Sales	5.48	EPS Y/Y TTM	-100.40%	Oper. Margin	-401.03%	ATR (14)	0.11	Perf 10Y	-69.41%
Dividend Ex-Date	-	Quick Ratio	5.87	Sales Y/Y TTM	-23.99%	Profit Margin	-430.93%	RSI (14)	72.44	Recom	2.21
Dividend Gr. 3/5Y	- -	Current Ratio	6.68	EPS Q/Q	-394.93%	SMA20	27.44%	Beta	2.15	Target Price	1.96
Payout	-	Debt/Eq	7.63	Sales Q/Q	-4.27%	SMA50	39.93%	Rel Volume	1.46	Prev Close	1.49
Employees	575	LT Debt/Eq	7.60	Earnings	May 08 AMC	SMA200	2.34%	Avg Volume	9.40M	Price	1.60
IPO	Oct 27, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	-649.61% 4.83%	Trades		Volume	13,771,386	Change	7.38%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-11-24	Downgrade	UBS	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30

Show Previous Ratings

Jul-03-25 09:08AM	Pacific Biosciences Targets Profitability by 2027 With Record Consumables Revenue (Insider Monkey) +7.38%
Jun-30-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: What You Should Know (Zacks)
08:50AM	The 5 Most Interesting Analyst Questions From PacBio's Q1 Earnings Call (StockStory)
Jun-13-25 11:30AM	Why Is Steris (STE) Down 1.8% Since Last Earnings Report? (Zacks)
Jun-12-25 06:15PM	Pacific Biosciences of California (PACB) Outperforms Broader Market: What You Need to Know (Zacks)
06:41AM	Loading…
Jun-10-25 06:41AM	PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market Headwinds (StockStory)
Jun-05-25 12:07PM	Here's Why You Should Add PacBio Stock to Your Portfolio Now (Zacks)
Jun-04-25 11:31PM	Q1 Earnings Roundup: PacBio (NASDAQ:PACB) And The Rest Of The Life Sciences Tools & Services Segment (StockStory)
Jun-02-25 10:00AM	Target ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date (PR Newswire)
May-29-25 12:00PM	All You Need to Know About Pacific Biosciences (PACB) Rating Upgrade to Buy (Zacks) -5.45%
May-28-25 09:00AM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) +20.85%
May-23-25 10:46AM	PacBio Stock Slips Despite New China Distribution Deal With Haorui (Zacks)
May-22-25 09:05AM	PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene (GlobeNewswire)
May-12-25 01:04PM	PACB Stock May Rise Following the Deal With Chulalongkorn University (Zacks)
10:56AM	PacBio Board Independent Investigation Concludes Allegations Unsubstantiated (GlobeNewswire)
12:00PM	Loading…
May-09-25 12:00PM	PacBio Stock Down Despite Q1 Earnings & Revenue Beat Estimates (Zacks) -6.67%
May-08-25 09:00PM	Pacific Biosciences (PACB) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks) +6.19%
05:30PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:29PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	PacBio Announces First Quarter 2025 Financial Results (GlobeNewswire)
May-07-25 12:38PM	Pacific Biosciences of California Q1 2025 Earnings Preview (Seeking Alpha)
11:08AM	Earnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 Result (GuruFocus.com)
May-05-25 09:05AM	First Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in Thailand (GlobeNewswire)
Apr-29-25 06:15PM	Pacific Biosciences of California (PACB) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Apr-28-25 09:05AM	PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry (GlobeNewswire)
09:01AM	1 Volatile Stock to Target This Week and 2 to Keep Off Your Radar (StockStory)
Apr-23-25 06:15PM	Pacific Biosciences of California (PACB) Flat As Market Gains: What You Should Know (Zacks)
Apr-22-25 09:05AM	Davos Alzheimer's Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer's Disease Research in North Africa (GlobeNewswire)
Apr-09-25 02:38PM	PacBio (PACB) and Hims & Hers Health (HIMS), 10x Genomics (TXG), Moderna (MRNA) Shares Are Soaring, What You Need To Know (StockStory) +20.83%
09:05AM	PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million (GlobeNewswire)
07:45PM	Loading…
Apr-04-25 07:45PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +7.32%
Mar-27-25 09:05AM	Jim Gibson to join PacBio as Chief Financial Officer (GlobeNewswire)
Mar-20-25 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
01:05PM	Here's Why You Should Retain PacBio Stock in Your Portfolio Now (Zacks)
Mar-18-25 06:15PM	Is Pacific Biosciences of California, Inc. (PACB) the Most Volatile Stock Under $3 For Day Trading? (Insider Monkey)
05:08AM	3 Reasons to Sell PACB and 1 Stock to Buy Instead (StockStory)
Mar-17-25 09:05AM	Scientists Solve One of Genomics' Biggest Challenges by Using HiFi Sequencing to Distinguish Highly Similar Paralogous Genes (GlobeNewswire)
05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-14-25 06:15PM	Pacific Biosciences of California (PACB) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
Mar-11-25 09:01AM	1 Healthcare Stock to Target This Week and 2 to Turn Down (StockStory) -5.76%
Feb-19-25 04:05PM	PacBio to Participate in TD Cowen's 45th Annual Health Care Conference (GlobeNewswire) -5.35% -7.34%
Feb-15-25 11:02AM	PacBio should return to growth over time, says Canaccord (TipRanks)
Feb-14-25 11:09PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire) +25.00%
02:21AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Feb-13-25 06:00PM	Compared to Estimates, Pacific Biosciences (PACB) Q4 Earnings: A Look at Key Metrics (Zacks) +8.82%
05:20PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
05:13PM	PacBio (NASDAQ:PACB) Misses Q4 Sales Targets (StockStory)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results (GlobeNewswire)
Feb-12-25 08:03AM	PacBio (PACB) Q4 Earnings Report Preview: What To Look For (StockStory)
07:42AM	Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Feb-04-25 06:15PM	Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why (Zacks) +13.89%
Feb-03-25 09:05AM	PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service (GlobeNewswire) -5.19%
Jan-30-25 04:05PM	PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025 (GlobeNewswire)
09:05AM	PacBio Announces Appointment of Chris Smith to Board of Directors (GlobeNewswire)
Jan-29-25 09:05AM	PacBio Technology Powers Landmark Multiomic Study Published in Nature Genetics (GlobeNewswire)
Jan-27-25 06:15PM	Pacific Biosciences of California (PACB) Stock Moves -1.18%: What You Should Know (Zacks)
Jan-24-25 09:16AM	PacBio announces GIFS at USask as first Revio PacBio CSP in Canada (TipRanks)
Jan-23-25 09:05AM	PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider (GlobeNewswire) -8.84%
Jan-14-25 09:05AM	PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics (GlobeNewswire) -7.96%
09:00AM	PacBio Announces Preliminary Fourth Quarter and Full Year Revenue (GlobeNewswire)
Jan-10-25 06:05AM	PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing (GlobeNewswire)
Jan-08-25 09:05AM	PacBio Announces Shipment of Vega Systems to Berry Genomics to Support its Clinical Assay Development for Asian Markets (GlobeNewswire)
Jan-07-25 06:15PM	Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today (Zacks)
11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-02-25 04:05PM	PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) +10.56%
Dec-30-24 03:03PM	Why Is Pacific Biosciences of California, Inc. (PACB) Among the Top CRISPR Stocks to Invest In? (Insider Monkey)
Dec-11-24 11:50AM	Why Pacific Biosciences of California (PACB) Is the Worst ARK Stock to Buy According to Short Sellers (Insider Monkey)
Nov-19-24 07:01PM	Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey) +9.55%
Nov-12-24 11:55AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool) -10.37%
Nov-08-24 04:05PM	PacBio to Present at Upcoming Investor Conferences (GlobeNewswire) -6.12% +6.96%
06:03AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Call Highlights: Navigating ... (GuruFocus.com)
Nov-07-24 07:30PM	Pacific Biosciences (PACB) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks) -7.55%
06:15PM	Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
05:14PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Third Quarter 2024 Financial Results (GlobeNewswire)
04:03PM	PacBio Announces a Private Convertible Exchange Transaction of $459 Million Principal Amount of 1.50% Convertible Senior Notes due 2028 (GlobeNewswire)
Nov-06-24 10:35PM	PacBio Unveils the Vega System, a New Sequencing Platform Bringing HiFi to the Benchtop (GlobeNewswire)
07:30AM	Pacific Biosciences of California Inc (PACB) Q3 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Nov-04-24 09:16AM	Curious about Pacific Biosciences (PACB) Q3 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
Oct-31-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks) +12.44%
Oct-30-24 02:57PM	Pacific Biosciences (PACB): Promising Gene Editing Stock With Innovating Technology (Insider Monkey)
10:13AM	Volta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep (PR Newswire)
Oct-29-24 09:05AM	PacBio Announces SPRQ Chemistry for Revio Sequencing Systems, a Major Advance Reducing the Cost of a HiFi Human Genome to less than $500 (GlobeNewswire) +11.96%
Oct-22-24 09:05AM	PacBio Onso Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program (GlobeNewswire)
Oct-16-24 06:15PM	Pacific Biosciences of California (PACB) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks) -7.77%
Oct-11-24 09:05AM	PacBio Enters Cancer Genomics Research Collaboration in Singapore with Advanced Onso Sequencing (GlobeNewswire) +27.74%
Oct-10-24 04:05PM	PacBio to Report Third Quarter 2024 Financial Results on November 7, 2024 (GlobeNewswire)
Oct-01-24 09:05AM	PacBio, A*STAR, and Macrogen Unveil State-of-the-Art Lab to Accelerate Genomics Innovation in Singapore (GlobeNewswire)
Sep-27-24 06:15PM	Pacific Biosciences of California (PACB) Advances While Market Declines: Some Information for Investors (Zacks)
04:05PM	PacBio Grants Equity Incentive Award to New Employee (GlobeNewswire)
Sep-13-24 06:15PM	Pacific Biosciences of California (PACB) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Sep-11-24 12:38PM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
09:05AM	PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific (GlobeNewswire)
Sep-08-24 04:51PM	Pacific Biosciences of California, Inc. (PACB): Among the Worst ARK Stocks According to Short Sellers (Insider Monkey)
11:49AM	10 Worst ARK Stocks To Buy According To Short Sellers (Insider Monkey)
Sep-04-24 09:05AM	Revio to Power Research in Male Infertility and Rare Disease at Munster University Hospital (GlobeNewswire)
09:05AM	Revio to Power Research in Male Infertility and Rare Disease at M nster University Hospital (GlobeNewswire)
Aug-26-24 04:03PM	PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire) -8.13%
Aug-12-24 12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's Why (Zacks) -10.06%

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Farmer Michele	See Remarks	May 19 '25	Sale	1.00	5,195	5,200	269,259	May 21 04:09 PM
HENRY CHRISTIAN O	See Remarks	Mar 03 '25	Sale	1.41	12,497	17,583	2,225,357	Mar 05 04:37 PM
Van Oene Mark	See Remarks	Mar 03 '25	Sale	1.41	6,486	9,126	1,497,695	Mar 05 04:37 PM
Farmer Michele	See Remarks	Mar 03 '25	Sale	1.41	2,973	4,183	184,619	Mar 05 04:36 PM
MARK VAN OENE	Officer	Mar 03 '25	Proposed Sale	1.41	6,486	9,123		Mar 03 05:11 PM
CHRISTIAN HENRY	Officer	Mar 03 '25	Proposed Sale	1.41	12,497	17,578		Mar 03 05:06 PM
Farmer Michele	See Remarks	Feb 18 '25	Sale	1.88	24,349	45,727	187,592	Feb 19 05:00 PM
Van Oene Mark	See Remarks	Feb 18 '25	Sale	1.88	100,773	189,252	1,496,681	Feb 19 04:59 PM
HENRY CHRISTIAN O	See Remarks	Feb 18 '25	Sale	1.88	259,909	488,109	2,237,854	Feb 19 04:58 PM
CHRISTIAN HENRY	Officer	Feb 18 '25	Proposed Sale	1.88	259,909	488,109		Feb 18 05:59 PM
MARK VAN OENE	Officer	Feb 18 '25	Proposed Sale	1.88	100,773	189,252		Feb 18 05:56 PM
Van Oene Mark	See Remarks	Jan 10 '25	Sale	2.03	34,405	69,980	1,597,454	Jan 10 04:54 PM
MARK VAN OENE	Officer	Jan 10 '25	Proposed Sale	2.03	34,405	69,980		Jan 10 04:23 PM
Kim Susan G.	See Remarks	Sep 30 '24	Sale	1.72	19,782	34,065	695,654	Oct 02 04:13 PM
SUSAN KIM	Officer	Sep 30 '24	Proposed Sale	1.72	19,782	34,061		Sep 30 04:03 PM
HENRY CHRISTIAN O	See Remarks	Sep 16 '24	Sale	1.75	98,907	172,692	2,497,763	Sep 17 04:11 PM
CHRISTIAN HENRY	Officer	Sep 16 '24	Proposed Sale	1.75	98,907	172,741		Sep 16 05:40 PM
Eidel Jeff	See Remarks	Aug 19 '24	Sale	1.59	26,760	42,602	869,730	Aug 20 05:27 PM
Van Oene Mark	See Remarks	Aug 16 '24	Sale	1.66	38,011	63,174	1,630,815	Aug 20 05:25 PM
JEFFREY EIDEL	Officer	Aug 19 '24	Proposed Sale	1.59	26,760	42,589		Aug 19 04:24 PM
MARK VAN OENE	Officer	Aug 16 '24	Proposed Sale	1.66	38,011	63,189		Aug 16 04:29 PM

Open in Screener

MRNA

Moderna Inc

Jul 03 • 04:00PM ET

30.49

Dollar change +0.21
Percentage change 0.69	%

Healthcare • Biotechnology • USA • NASD

Peers: BNTX NVAX REGN ALNY INCY BMRN SRPT VRTX GILD BIIB

| Held by: VTI VOO RSP XBI SPY IVV VB VO VBR XLV

Index	S&P 500	P/E	-	EPS (ttm)	-8.72	Insider Own	11.44%	Shs Outstand	387.00M	Perf Week	10.71%
Market Cap	11.79B	Forward P/E	-	EPS next Y	-7.47	Insider Trans	0.43%	Shs Float	342.49M	Perf Month	9.64%
Enterprise Value	6.56B	PEG	-	EPS next Q	-2.96	Inst Own	72.20%	Short Float	18.56%	Perf Quarter	9.99%
Income	-3357.00M	P/S	3.71	EPS this Y	-8.51%	Inst Trans	1.44%	Short Ratio	5.80	Perf Half Y	-22.57%
Sales	3.18B	P/B	1.17	EPS next Y	25.85%	ROA	-22.81%	Short Interest	63.56M	Perf YTD	-26.67%
Book/sh	26.01	P/C	1.97	EPS next 5Y	20.72%	ROE	-29.34%	52W High	129.39 -76.44%	Perf Year	-73.70%
Cash/sh	15.45	P/FCF	-	EPS past 3/5Y	- -42.94%	ROIC	-31.18%	52W Low	23.15 31.71%	Perf 3Y	-78.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.99% 121.86%	Gross Margin	48.06%	Volatility	5.98% 4.57%	Perf 5Y	-50.24%
Dividend TTM	-	EV/Sales	2.07	EPS Y/Y TTM	44.29%	Oper. Margin	-117.37%	ATR (14)	1.41	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.14	Sales Y/Y TTM	-38.25%	Profit Margin	-105.67%	RSI (14)	67.79	Recom	2.86
Dividend Gr. 3/5Y	- -	Current Ratio	4.22	EPS Q/Q	18.22%	SMA20	11.87%	Beta	1.82	Target Price	43.85
Payout	-	Debt/Eq	0.07	Sales Q/Q	-35.33%	SMA50	14.20%	Rel Volume	0.64	Prev Close	30.28
Employees	5800	LT Debt/Eq	0.07	Earnings	May 01 BMO	SMA200	-20.22%	Avg Volume	10.96M	Price	30.49
IPO	Dec 07, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	19.13% 1.71%	Trades		Volume	6,972,516	Change	0.69%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Neutral	$40
Feb-18-25	Downgrade	Barclays	Overweight → Equal Weight	$111 → $45
Jan-29-25	Downgrade	Goldman	Buy → Neutral	$99 → $51
Dec-18-24	Downgrade	Argus	Buy → Hold
Dec-10-24	Resumed	BofA Securities	Underperform	$41
Nov-19-24	Initiated	Berenberg	Hold	$42
Nov-18-24	Upgrade	HSBC Securities	Hold → Buy	$58
Nov-15-24	Initiated	Wolfe Research	Underperform	$40
Oct-17-24	Initiated	Bernstein	Mkt Perform	$55
Sep-13-24	Downgrade	Oppenheimer	Outperform → Perform
Sep-13-24	Downgrade	JP Morgan	Neutral → Underweight	$88 → $70
Sep-13-24	Downgrade	Jefferies	Buy → Hold	$120 → $65
Aug-28-24	Upgrade	HSBC Securities	Reduce → Hold	$82
Aug-07-24	Upgrade	Deutsche Bank	Sell → Hold	$85 → $80
Aug-05-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$125 → $90
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60

Show Previous Ratings

Today 07:45AM	2 Beaten-Down Stocks to Buy and Hold (Motley Fool)
05:10AM	Where Will Moderna Be in 10 Years? (Motley Fool)
Jul-04-25 03:07PM	Why Moderna Stock Was So Healthy This Week (Motley Fool)
Jul-03-25 09:36AM	Robert F. Kennedy Jr. Just Did The Unexpected. He Helped Moderna. (Investor's Business Daily)
09:06AM	MRNA Stock Jumps on CDC's Revised RSV Vaccine Recommendations (Zacks)
04:33PM	Loading…
Jul-02-25 04:33PM	Kennedy Expands RSV Vaccine Recommendations. Moderna, Pfizer Shares Are Up. (Barrons.com) +5.54%
01:22PM	RFK Jr. Just Did The Unexpected. He Helped Moderna. (Investor's Business Daily)
Jul-01-25 01:02PM	Improved Pharma initiates research and development program (PR Newswire)
12:31PM	Analyst Report: Moderna, Inc. (Morningstar Research)
09:17AM	Moderna Stock Gains on Encouraging Flu Vaccine Data (Zacks)
08:30AM	Former Moderna Chief Development Officer Melanie Ivarsson OBE Joins PhaseV's Scientific Advisory Board (PR Newswire)
07:15AM	Got $200? 2 Biotech Stocks to Buy and Hold Forever (Motley Fool)
05:00AM	Company News for Jul 1, 2025 (Zacks)
Jun-30-25 07:53PM	Analyst Report: Moderna, Inc. (Morningstar Research)
12:40PM	Modernas mRNA flu shot outperforms current standard at Phase III (Clinical Trials Arena)
12:06PM	Loading…
12:06PM	Moderna Stock Is Climbing on Trial Data. A Flu-Covid Vaccine Isn't a Sure Thing. (Barrons.com)
11:57AM	Top Stock Movers Now: Hewlett Packard Enterprise, Moderna, Tesla, and More (Investopedia)
10:38AM	Moderna Shares Jump With Positive Test Results for MRNA Flu Vaccine (The Wall Street Journal)
10:09AM	Did Down-And-Out Moderna Just Unlock The Key To Its Future Profitability? (Investor's Business Daily)
10:07AM	Stocks See Support as Signs of Trade Progress Boost Market Sentiment (Barchart)
09:38AM	Solar stocks, Moderna, HPE: Trending Tickers (Yahoo Finance Video)
08:30AM	Vertex Down Around 9% in Three Months: Should You Buy, Sell or Hold the Stock? (Zacks)
08:08AM	Palantir recovers a chunk of Friday's sell-off, and other early market movers (MarketWatch)
07:00AM	Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine (ACCESSWIRE)
Jun-27-25 09:35AM	Cancer Vaccine (Preventative, Therapeutic) Market Research 2025 with Analyst Recommendations-Leveraging AI and Bioinformatics for Precision Development / Pursue Fast-Track and Orphan Drug Designations (GlobeNewswire)
Jun-26-25 05:50PM	Moderna (MRNA) Outperforms Broader Market: What You Need to Know (Zacks)
02:28PM	The Anti-Vax Movement Solidifies Control of the CDC's Vaccine Committee (Barrons.com)
02:55AM	The Top 5 Analyst Questions From Moderna's Q1 Earnings Call (StockStory)
Jun-25-25 01:41PM	Seeking a Cure for Sickly Corporate Governance at SinoVac (CorpGov.com)
09:59AM	Merck Moves Past 50-Day Average: How to Play MRK Stock Now (Zacks)
12:02AM	Loading…
12:02AM	Moderna (MRNA): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jun-24-25 04:27PM	Moderna, Inc. (MRNA): A Bull Case Theory (Insider Monkey)
03:09PM	Moderna RSV Vaccine Gains Expanded FDA Approval for Younger Adults (Insider Monkey)
Jun-20-25 05:50PM	Moderna (MRNA) Advances While Market Declines: Some Information for Investors (Zacks)
Jun-16-25 05:09PM	S&P 500 Gains and Losses Today: AMD Stock Soars as Analyst Praises Next-Gen Server Rack Architecture (Investopedia)
11:20AM	EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy (Zacks)
Jun-13-25 05:50PM	Here's Why Moderna (MRNA) Fell More Than Broader Market (Zacks)
12:15PM	Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz (TipRanks)
08:42AM	Moderna falls on doubts over new CDC panel's backing of RSV vaccine (Reuters)
08:14AM	Modernas mRNA RSV vaccine wins expanded FDA approval for younger adults (Pharmaceutical Technology)
07:37AM	Moderna wins FDA OK to widen use of RSV vaccine (BioPharma Dive)
12:39AM	3 Healthcare Stocks with Questionable Fundamentals (StockStory)
Jun-12-25 07:25PM	Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18-59 at Increased Risk for RSV Disease (ACCESSWIRE)
11:19AM	Moderna explores outside financing for vaccine trials, shares dip (Investing.com)
08:15AM	Novavax's COVID-Flu Combo Shot Shows Strong Immune Response (Zacks)
04:25AM	Is it Time to Dump Your Shares of Moderna? (Motley Fool)
Jun-11-25 10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
10:20AM	Kennedy Pledges to Immediately Replace Vaccine Advisors, Shortcutting Vetting Process (Barrons.com)
07:00AM	Moderna to Present at Upcoming Barclays Speaking the Science Call Series on June 16, 2025 (ACCESSWIRE)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
10:19AM	BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom (Bloomberg)
10:10AM	RFK Jr. removes CDC vaccine panel members: What to know (Yahoo Finance Video)
09:46AM	Will Merck's Keytruda Continue to Drive Growth Amid Looming LOE? (Zacks)
08:18AM	Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. (Barrons.com)
Jun-09-25 07:12PM	RFK Jr. Fires All 17 Members of CDC's Vaccine Advisory Board (Barrons.com)
06:09PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
Jun-06-25 05:06PM	S&P 500 Gains and Losses Today: Lululemon Stock Falls as Forecasts Reflect Consumer Caution (Investopedia) +5.13%
04:16PM	Challenges pharma companies face in push into US manufacturing (Yahoo Finance Video)
04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
11:31AM	Why Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report? (Zacks)
Jun-05-25 11:30AM	Why Is Denali Therapeutics (DNLI) Up 0.7% Since Last Earnings Report? (Zacks)
Jun-04-25 11:30AM	Why Is Axsome (AXSM) Down 1.8% Since Last Earnings Report? (Zacks)
04:15AM	Down 80%, Should You Buy the Dip on Moderna? (Motley Fool)
Jun-03-25 12:16PM	Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike (Zacks)
09:23AM	Company News for Jun 3, 2025 (Zacks)
07:59AM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
Jun-02-25 09:00PM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
04:41PM	These Stocks Are Moving the Most Today: Cleveland-Cliffs, Tesla, GM, Blueprint Medicines, BioNTech, DraftKings, and More (Barrons.com)
02:35PM	What you need to know about Modernas new COVID vaccine, just approved by the FDA (Fortune)
01:30PM	Two biopharma stocks to consider outside of Moderna (Yahoo Finance Video)
12:09PM	Top Stock Movers Now: Ford, Cleveland-Cliffs, Moderna, and More (Investopedia)
11:39AM	Bristol Myers Joins Pharma's Hottest Horserace in $11.1B Deal With BioNTech (Barrons.com)
10:38AM	Tesla EU sales, FDA & Moderna, DraftKings: Trending Tickers (Yahoo Finance Video)
09:49AM	Moderna Stock Is Rising. A New Covid Vaccine Is Coming But Only for Some. (Barrons.com)
09:46AM	Stocks to Watch Monday: Alphabet, Tesla, UnitedHealth, Steel Dynamics (The Wall Street Journal)
09:46AM	Moderna Stock Climbs as FDA Approves New COVID-19 Vaccine (Investopedia)
09:43AM	Analyst Report: Moderna, Inc. (Morningstar Research)
08:37AM	Moderna Stock Is Rising. A New Covid Vaccine Is Coming for Some People. (Barrons.com)
08:35AM	Moderna's New COVID Vaccine Secures FDA-Clearance For Seniors, At-Risk Individuals (Benzinga)
06:29AM	Moderna gains as FDA nod for next-gen COVID-19 vaccine (Investing.com)
May-31-25 01:05PM	FDA approves Moderna's new lower-dose COVID-19 vaccine (Associated Press Finance)
09:30AM	FDA clears Modernas new COVID vaccine, but with limits (BioPharma Dive)
12:16AM	Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE (ACCESSWIRE)
May-30-25 10:00AM	Pharma Stock Roundup: LLY's New Deal, GSK & SNY's Pipeline Updates (Zacks)
May-29-25 05:06PM	Trump admin. cancels Moderna bird fu vaccine contract (Yahoo Finance Video)
01:08PM	HHS cancels Moderna award, GE Vernova, Amazon-NY Times AI deal (Yahoo Finance Video)
01:07PM	HHS cancels Moderna contract for development of bird flu vaccine for humans (CNBC TV)
01:01PM	HHS cancels $766m bird flu vaccine contract with Moderna (Pharmaceutical Technology)
11:08AM	U.S. Govt. Cancels $766M Funding Contract for Moderna's Bird Flu Shot (Zacks)
11:01AM	Moderna Is Imperiled by Kennedys Health Department. It May Run Out of Cash. (Barrons.com)
09:06AM	HHS cancels Moderna bird flu deal (CNBC TV)
07:45AM	HHS terminates Moderna contract to develop bird flu vaccine (BioPharma Dive)
07:36AM	Moderna suffers a $750 million loss from NIH funding cut (Yahoo Finance)
May-28-25 11:43PM	Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut (Insider Monkey)
08:01PM	Trump administration cancels $766 million Moderna contract to fight pandemic flu (Associated Press Finance)
06:06PM	US cancels more than $700 million funding for Moderna bird flu vaccine (Reuters)
May-27-25 07:00AM	Moderna to Present at Upcoming Conferences in June 2025 (ACCESSWIRE)
May-26-25 11:35AM	Jim Cramer on Moderna (MRNA): "I've Been Against This Stock For So Long" (Insider Monkey)
11:01AM	MRK Down 21% YTD: Should You Buy, Hold or Sell the Stock? (Zacks)
09:41AM	MRNA Seeks FDA Nod for Updated COVID-19 Vaccine (Zacks)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hussain Abbas	Director	Jun 11 '25	Sale	28.00	312	8,736	580	Jun 12 04:22 PM
Hussain Abbas	Director	Jun 11 '25	Proposed Sale	28.00	312	8,736		Jun 11 10:06 AM
Bancel Stephane	Chief Executive Officer	Mar 03 '25	Buy	31.22	160,314	5,004,318	9,210,686	Mar 04 04:27 PM
SAGAN PAUL	Director	Mar 03 '25	Buy	31.76	31,620	1,004,251	312,027	Mar 04 04:24 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 09 '24	Sale	44.68	529	23,637	20,446	Dec 10 04:08 PM
Klinger Shannon Thyme	Officer	Dec 09 '24	Proposed Sale	44.68	529	23,637		Dec 09 03:18 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 03 '24	Sale	43.30	112	4,849	19,837	Dec 04 05:11 PM
Hoge Stephen	President	Dec 03 '24	Sale	43.30	314	13,595	1,443,904	Dec 04 05:08 PM
Klinger Shannon Thyme	Officer	Dec 03 '24	Proposed Sale	43.30	112	4,849		Dec 03 04:11 PM
Hoge Stephen	Officer	Dec 03 '24	Proposed Sale	43.30	314	13,595		Dec 03 03:23 PM
Mock James M	Chief Financial Officer	Nov 29 '24	Sale	42.79	1,420	60,761	11,066	Dec 02 04:26 PM
Klinger Shannon Thyme	Chief Legal Officer	Nov 29 '24	Sale	42.79	1,418	60,675	19,717	Dec 02 04:19 PM
Hoge Stephen	President	Nov 29 '24	Sale	42.79	291	12,452	1,443,567	Dec 02 04:15 PM
Hoge Stephen	Officer	Nov 29 '24	Proposed Sale	42.79	291	12,452		Nov 29 03:54 PM
Klinger Shannon Thyme	Officer	Nov 29 '24	Proposed Sale	42.79	1,418	60,675		Nov 29 03:49 PM
Mock James M	Officer	Nov 29 '24	Proposed Sale	42.79	1,420	60,761		Nov 29 03:35 PM
Hoge Stephen	President	Nov 11 '24	Sale	46.10	277	12,771	1,443,248	Nov 12 04:14 PM
Hoge Stephen	Officer	Nov 11 '24	Proposed Sale	46.10	277	12,771		Nov 12 09:27 AM
Mock James M	Chief Financial Officer	Oct 07 '24	Sale	60.12	715	42,986	9,505	Oct 08 04:19 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 09 '24	Sale	73.57	551	40,539	18,154	Sep 10 04:15 PM
Klinger Shannon Thyme	Officer	Sep 09 '24	Proposed Sale	73.57	551	40,539		Sep 09 03:29 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 03 '24	Sale	76.99	114	8,777	17,566	Sep 04 05:42 PM
Hoge Stephen	President	Sep 03 '24	Sale	76.99	318	24,483	1,443,002	Sep 04 04:26 PM
Klinger Shannon Thyme	Officer	Sep 03 '24	Proposed Sale	76.99	114	8,777		Sep 03 03:58 PM
Hoge Stephen	Officer	Sep 03 '24	Proposed Sale	76.99	318	24,482		Sep 03 03:42 PM
Mock James M	Chief Financial Officer	Aug 29 '24	Sale	78.03	162	12,640	8,767	Aug 30 04:37 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 29 '24	Sale	78.03	162	12,640	17,447	Aug 30 04:34 PM
Hoge Stephen	President	Aug 29 '24	Sale	78.03	300	23,408	1,442,668	Aug 30 04:32 PM
Mock James M	Chief Financial Officer	Aug 28 '24	Sale	79.39	1,321	104,881	8,600	Aug 29 04:45 PM
Klinger Shannon Thyme	Chief Legal Officer	Aug 28 '24	Sale	79.39	1,319	104,722	17,280	Aug 29 04:03 PM
Klinger Shannon Thyme	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:52 PM
Mock James M	Officer	Aug 29 '24	Proposed Sale	78.03	162	12,640		Aug 29 03:43 PM
Hoge Stephen	Officer	Aug 29 '24	Proposed Sale	78.03	300	23,408		Aug 29 03:38 PM
Mock James M	Officer	Aug 28 '24	Proposed Sale	79.39	1,321	104,881		Aug 28 04:47 PM
Klinger Shannon Thyme	Officer	Aug 28 '24	Proposed Sale	79.39	1,319	104,722		Aug 28 04:30 PM
Hoge Stephen	President	Aug 12 '24	Sale	84.10	254	21,363	1,442,357	Aug 13 04:33 PM
Hoge Stephen	Officer	Aug 12 '24	Proposed Sale	84.10	254	21,363		Aug 12 04:05 PM
AFEYAN NOUBAR	Director	Jul 31 '24	Sale	119.96	15,000	1,799,443	2,224,015	Aug 02 07:00 PM
NOUBAR B AFEYAN	Director	Jul 31 '24	Proposed Sale	118.84	15,000	1,782,600		Jul 31 04:18 PM
AFEYAN NOUBAR	Director	Jul 24 '24	Sale	117.80	15,000	1,766,972	2,239,015	Jul 26 07:00 PM
AFEYAN NOUBAR	Director	Jul 17 '24	Sale	122.84	15,000	1,842,651	2,254,015	Jul 19 07:00 PM
Hoge Stephen	President	Jul 15 '24	Sale	121.12	15,000	1,816,800	1,442,089	Jul 16 04:08 PM
AFEYAN NOUBAR	Director	Jul 10 '24	Sale	117.08	15,000	1,756,177	2,269,015	Jul 12 07:00 PM
Mock James M	Chief Financial Officer	Jul 08 '24	Sale	118.24	689	81,465	7,269	Jul 09 04:34 PM

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience